InvestorsHub Logo
icon url

TradingPro

11/05/21 6:18 PM

#382188 RE: multiples #382187

It’s really slight at hand or invalid to compare to Merck’s antiviral. . Merck’s antiviral maybe just as good or better. Wonder if Merck will call them out on it. Looks like IPIX is very much in the game. No competition yet for moderate to severe CV. Now we should go after mild! Stick it to them!!! See those who sold are now out of the game , why you don’t sell on emotions, and limited knowledge.
icon url

shazamm

11/05/21 6:39 PM

#382190 RE: multiples #382187

Exactly, all of the company goals are still in front it & very attainable.